Healthcare >> CEO Interviews >> April 28, 2003
BIN HUANG, President and Chief Executive Officer of WEX Pharmaceuticals Inc.,
joined the company in November 2007. Her previous experience includes two years
as CEO of GeneHarbour Technologies (Hong Kong) and five years as President and
CEO of Cytovax Biotechnologies Inc. in Canada. Additionally, she served as Vice
President of Business Development at Monsanto Canada, and was a top-ranked
biotech analyst in Canada while she was a partner at GMP Securities. Dr. Huang
received her PhD in Cell Biology from the University of East Anglia, UK, and her
MBA from the University of Toronto. Profile
focus?
Dr. Huang: Cytovax is a biotechnology company. We develop peptide
vaccines and therapeutic antibodies for bacterial
